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Abstract— In spite of the fact that commercial bromelain 
supplements are available in the market, to date, none of 
them are produced and formulated from recombinant 
forms. They are extracted and purified (often partially) 
from the stem and fruit of pineapple. This makes the 
production of bromelain very difficult, less reliable, often 
contaminated and expensive. In this study, a recombinant 
bromelain from BL21 A clone was expressed as soluble 
and insoluble active enzyme. Maximum activity was 
observed at 4-hour post induction with 0.2% L-arabinose 
and over 60% of the enzyme was found to be expressed in 
soluble form. The enzyme fractions were purified using 
Nickel-NTA spin column. Purification fold and % yield of 
the purified lysate were found to be 35 and 75% 
respectively. SDS-PAGE results showed that the purified 
bromelain exhibited a single band with molecular weight 
of about 45kDa. 
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I. INTRODUCTION 
The use of purified proteins for therapeutical 
purposes has been in existence for many decades. 
Hormones such as insulin and human growth hormones, 
and other proteins were extracted and purified from 
blood and other tissues before the emergence of 
recombinant DNA technology [1]. Enzymes constitute 
the largest portion of these purified proteins for 
industrial and therapeutic applications. Since the 
approval of insulin in 1982, more than 120 recombinant 
drug substances have been approved and become 
available as extremely valuable therapeutic options [2].  
The name ‗‘bromelain‖ was originally given to a 
mixture of proteases found in the juice of the stem and 
fruit of pineapple (Ananas comosus). Even now, 
bromelain is still used as collective name for the 
enzymes found in various members of Bromeliaceae 
family. The major peptidase present in the extracts of 
plant stem is called stem ‗bromelain‘ while the major 
enzyme fraction found in the juice of pineapple fruit is 
named ‗fruit bromelain‘. Some other minor Cysteine 
endopeptidases (ananain, comosain) are also present in 
the pineapple stem bromelain.  
Stem bromelain (E.C.3.4.22.32), belonging to 
papain family, is a glycosylated single chain protein 
containing of about 212 amino acid residues including 
seven Cysteines, one of which is involved in catalysis 
[3]. Pure stem bromelain is stable when stored at -20
0
C 
and has optimum pH for activity at 6-8.5 for most of its 
substrates. The optimum temperature range for the 
enzyme is 50-60
o
C. It is mostly activated by cysteine 
while hydrogen sulphide and sodium cyanide are less 
effective [4]. However, heavy metals (like mercury and 
silver) and E-64 deactivate the enzyme. 
Bromelain also has greater therapeutical 
applications. It was firstly introduced as a therapeutic 
compound in 1957 [5]. Bromelain actions include: (1) 
inhibition of platelet aggregation; (2) fibrinolytic 
activity;(3) anti-inflammatory action;(4) anti-tumour 
action; (5) modulation of cytokines and immunity; (6) 
skin debridement properties; (7) enhanced absorption of 
other drugs;(8) mucolytic properties; (9) digestive 
assistance ; (10) enhanced wound healing; and (11) 
cardiovascular circulatory improvement [5]. It is also 
used in baking industries and meat tenderization. 
The use of conventional methods makes the 
production and formulation of bromelain very difficult, 
less reliable, often contaminated and expensive. 
Moreover, downstream processing is one of the major 
cost factors (up to 50%) in bioprocess. Hence, it is vital 
to develop efficient and cost effective processes that 
contribute towards the development of highly purified 
and cheaper bromelain. Consequently, this research 
work is geared towards the over expression of 
recombinant bromelain in  E .coli using shake flasks and  
a 2-liter bioreactor and then purifying the  enzyme using 
Nickel-NTA spin column chromatography. 
II. MATERIALS AND METHODS 
A. Chemical: All chemicals used were obtained from 
commercial sources and of highest purity. 
B. Over expression of Recombinant Bromelain 
E. coli cells harboring recombinant bromelain gene 
[6, 7] were grown over night in LB media (Luria 
Bertani) containing 100g/ml ampicillin until the 
OD600nm reached 0.6-1.0. The overnight culture was then 
diluted 100 fold in  afresh LB media containing 
100g/ml ampicillin and was grown at 37 oC and 
agitated at 250 rpm in  shake flasks and then a 2-L  
bioreactor up to a cell density of OD = 0.4.  Inducer (L-
arabinose) was then added to reach a final concentration 
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of 0.2% and the induction continued for 4 hours. Cells   
were harvested from the spent media by centrifugation 
(8,000 rpm, 4
 o
C, and 20 min) and stored at -20
o
c until 
used [8].  
C. Purification of the enzymes 
The harvested cells were subjected to sonication on 
ice using 6- 10 second burst with 10 seconds interval at 
high amplitude. This was followed by centrifugation at 
4
o
C, 12000 rpm for 30 minutes and supernatant was 
collected and purified by Nickel-NTA affinity 
chromatography. The enzymes were purified under 
native and denaturing conditions according to 
manufacturer‘s instructions. 
D. Protein Determination 
Proteins present in the enzyme preparations were 
determined by Bradford‘s method [9] using bovine 
serum albumin as standard. 
E. SDS-PAGE Electrophoresis 
After each step of purification, the protein fractions 
were tested by SDS-PAGE in 12.5% Polyacrylamide 
gels. Current was kept constant at 90V for 1 hour. 
Visualization was done by staining with Coomasie 
Brilliant blue R-250[10] 
 
 
Table 1: Purification Table of native and denatured bromelain 
Protein Vol. 
(ml) 
Total protein 
(mg) 
Activity 
(units) 
Total activity 
(units x ml) 
Specific 
activity 
(unit/mg) 
Purification fold %Yield 
Crude native 100 0.0184 0.556 55.6 30 1.0 100 
Purified 
Native 
50 0.0008 0.834 41.7 1039 35 75 
Crude 
denatured 
20 0.0852 0.214 4.28 2.5 1.0 100 
Purified 
Denatured 
10 0.0632 0.223 2.23 3.5 1.4 52 
 
F.   Measurement of Proteolytic Activity 
The assay was carried out by the Silverstein‘s [11] 
method modified to reach optimal conditions of the 
enzyme. The activity was studied using N-a-Cbz-L-Gln-
p-nitrophenyl ester as substrate. Assays were made at 
37
o
C in 0.1 M Tris–HCl buffer (pH8.0) containing 25 
mM cysteine and 1 mM of each substrate in the reaction 
mixture. Liberation of p-nitrophenol was followed 
spectrophotometrically at 405 nm using UV-visible 
spectroscopy system. An arbitrary enzyme activity unit 
(Ucbz) was defined as the amount of protease (g) that 
released one micromole of p-nitrophenolate per min in 
the assay conditions. 
III. RESULTS AND DISCUSSION 
The SDS-PAGE results of the bromelain are 
presented in Fig. 1. In (a) and (c), binding and elution 
efficiency of nickel-NTA spin column are depicted on 
native and denatured bromelain respectively. Single, 
homogenous band of bromelain, of molecular weight 
45kDa was obtained in (a). However, multiple bands for 
denatured bromelain were obtained in (b). The unfolded 
proteins in (b) might have trapped some proteins during 
purification process. In (c), the purified native proteins 
showed homogenous single bands of 45kDa molecular 
weight. 
From Table 1, it can be seen that the purification fold for 
both native and denatured bromelains are 35 and 1.4 while 
their corresponding % yield are 75 and 52 respectively. This 
implies that higher purification factor and yields were obtained 
in the native form of bromelain. 
CONCLUSION 
It can be concluded that the over expressed 
bromelain had over 60% of the protein as soluble form. 
In addition, higher yield   and purification factor had 
been achieved in the production of native form of 
bromelain. The results also indicated that a 
homogenous, single native bromelain, of molecular 
weight of about 45kda has been produced and purified. 
 
Fig 1: SDS-PAGE results for native and denatured bromelains 
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